ArticleThe Journal of pharmacology and experimental therapeutics2022

Central Nervous System Distribution of the Ataxia-Telangiectasia Mutated Kinase Inhibitor AZD1390: Implications for the Treatment of Brain Tumors.

Surabhi Talele et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.